TrialPloS one2023

Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).

Raja Dhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.